Focus on Melanoma Meeting 2024

Friday 18th October 2024

Organised by: A group of Dermatology Consultants

Location: The Royal College of Physicians, London

Registration for this event is now open

Friday, 18th October 20249:00 am – 5:10 pm

The early bird rate end Sunday 22nd September, register before then receive your place at a discount

CPD accreditation (6 credits) is being applied for. 

Poster abstracts to be submitted by Sunday 22nd September 2024 (250 words maximum) to jenn@melanomafocus.org

Registration

Member rates


Early Bird Rate
ConsultantOpen Form:£160
Other Clinician/AHPOpen Form:£120
Nurse/Medical StudentOpen Form:£59

Non-Member rates


Early Bird Rate
ConsultantOpen Form:£209
Other Clinician/AHPOpen Form£149
Nurse/Medical StudentOpen Form:£80
IndustryOpen Form:£339

Draft Programme

09:00 – 09:55

BMS SPONSORED SYMPOSIUM: 

New Era of Dual I-O: navigating conundrums in the treatment and care of advanced melanoma

Chair: Dr Heather Shaw, Consultant Medical Oncologist, Mount Vernon Cancer Centre and University College London Hospital

-Professor Paul Nathan, Consultant Medical Oncologist, Mount Vernon Cancer Centre

-Dr Toby Talbot, Consultant Medical Oncologist, Royal Cornwall Hospital

10:00 – 10:05

Welcome/Introductions

Dr Mark Harries, Consultant Medical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust and Chairman of Melanoma Focus

10:05 – 10:15

Melanoma Focus: Achievements and Plans

Dr Mark Harries and Susanna Daniels

10:15 – 11:10

Session 1:  New Developments and Clinical Trials

Chair:  Professor Catherine Harwood, Professor of Dermatology, Barts’ Health NHS Trust

 

10:15 – 10:45

Neo-adjuvant and other systemic treatment advance

Professor Paul Nathan, Consultant Medical Oncologist, Mount Vernon Cancer Centre

10:45 – 11:00

UK Skin Cancer Clinical Trials Group update

Dr Brent O’Carrigan, Consultant Medical Oncologist, Cambridge University Hospitals NHS Trust

11:00 – 11:10

Q&A

11:10 – 11:35

Break

11:35 – 12:50

Session 2:  Artificial Intelligence

Chairs: Professor Charlotte Proby, Professor of Dermatology and Honorary Consultant Dermatologist, Ninewells Hospital & Medical School and

Dr Rubeta Matin, Consultant Dermatologist and Honorary Senior Clinical Lecturer, Oxford University Hospitals NHS Foundation Trust

11:35 – 11:55

AI and Melanoma Diagnostics – where are we now?

Dr Rubeta Matin, Consultant Dermatologist and Honorary Senior Clinical Lecturer, Oxford University Hospitals NHS Foundation Trust

11:55 – 12:15

The potential role of AI supporting teledermatology services

The UK experience – pros and cons

Dr Carolyn Charman, Consultant Dermatologist, Royal Devon University Healthcare and Clinical Advisor for NHSX

12:15 – 12:35

AI Skin Cancer Consortium

Professor Colin Fleming, Consultant Dermatologist and Director of Innovation, NHS Tayside

12:35 – 12:50

Q&A

12:50 – 13:30

Session 3: Surgical Dilemmas

Chair: Professor Marc Moncrieff, Consultant Plastic Reconstructive Surgeon, Norfolk & Norwich University Hospitals NHS Foundation Trust

13:00 – 13:25

TBC

Mr Ewan Wilson, Consultant Plastic Reconstructive Surgeon, North Bristol NHS Trust

13:25 – 13:30

Q&A

13:30 – 14:30

Lunch

14:30 – 15:15

The Professor Martin Gore CBE Memorial Lecture

Introduction – Dr Mark Harries, Consultant Medical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust and Chairman of Melanoma Focus

 

From bench to bedside and back: what we have learned and what we are still missing 

 

Professor Dirk Schadendorf, Director and Chair, Department of Dermatology & Director, Comprehensive Cancer Center, University Hospital Essen, Germany

15:15 – 16:05

Session 4: Immunotherapy Toxicities

Chair:  Professor Catherine Harwood, Professor of Dermatology, Barts’ Health NHS Trus

15:15 – 15:40

Guidelines to manage dermatology IO toxicity

Dr Andy Muinonen-Martin, Consultant Dermatologist, Leeds Teaching Hospitals NHS Foundation Trust

15:40 – 16:00

Exploring the impact of patient genetics on melanoma responses and the development of side effects to immunotherapy

Professor Ben Fairfax, Professor of Cancer Immunogenetics, Wellcome Intermediate Clinical Fellow and Honorary Consultant Medical Oncologist, University of Oxford

16:00 – 16:10

Q&A

16:10 – 17:10

Session 5:  MDT:  Challenging toxicities 

Chair:  Dr Kate Young, Consultant Medical Oncologist, The Royal Marsden Hospital NHS Foundation Trust

Panel: tbc

17:10

Close

17:10 – 19:00

Drinks Reception and networking